The DOI matches its Crossref record; 116 of the 117 references it cites were found in a registry or an index.
Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial
Open accessAbstract
Importance: Major depressive disorder (MDD) remains challenging to treat. Although several clinical and demographic variables have been found to predict poor antidepressant response, these markers have not been robustly replicated to warrant implementation in clinical care. Increased pretreatment rostral anterior cingulate cortex (rACC) theta activity has been linked to better antidepressant outcomes. However, no prior study has evaluated whether this marker has incremental predictive validity over clinical and demographic measures. Objective: To determine whether increased pretreatment rACC theta activity would predict symptom improvement regardless of randomization arm. Design, Setting, and Participants: A multicenter randomized clinical trial enrolled outpatients without psychosis and with chronic or recurrent MDD between July 29, 2011, and December 15, 2015 (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care [EMBARC]). Patients were consecutively recruited from 4 university hospitals: 634 patients were screened, 296 were randomized to receive sertraline hydrochloride or placebo, 266 had electroencephalographic (EEG) recordings, and 248 had usable EEG data. Resting EEG data were recorded at baseline and 1 week after trial onset, and rACC theta activity was extracted using source localization. Intent-to-treat analysis was conducted. Data analysis was performed from October 7, 2016, to January 19, 2018. Interventions: An 8-week course of sertraline or placebo. Main Outcomes and Measures: The 17-item Hamilton Rating Scale for Depression score (assessed at baseline and weeks 1, 2, 3, 4, 6, and 8). Results: The 248 participants (160 [64.5%] women, 88 [35.5%] men) with usable EEG data had a mean (SD) age of 36.75 (13.15) years. Higher rACC theta activity at both baseline (b = -1.05; 95% CI, -1.77 to -0.34; P = .004) and week 1 (b = -0.83; 95% CI, -1.60 to -0.06; P < .04) predicted greater depressive symptom improvement, even when controlling for clinical and demographic variables previously linked with treatment outcome. These effects were not moderated by treatment arm. The rACC theta marker, in combination with clinical and demographic variables, accounted for an estimated 39.6% of the variance in symptom change (with 8.5% of the variance uniquely attributable to the rACC theta marker). Conclusions and Relevance: Increased pretreatment rACC theta activity represents a nonspecific prognostic marker of treatment outcome. This is the first study to date to demonstrate that rACC theta activity has incremental predictive validity. Trial Registration: clinicaltrials.gov Identifier: NCT01407094.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An imbalance between two primary central nervous system (CNS) neurotransmitters, L-glutamate and γ-aminobutyric acid (GABA), has emerged as having a key role in the pathophysiology of TRD.”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [22]
In the citing paper
“Glutamatergic and GABAergic dysfunction in the prefrontal cortex (PFC) and anterior cingulate cortex (ACC) has been extensively implicated in both MDD and TRD [16,17,18,19,20,21,22,23,24,25].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [22]
In the citing paper
“In contrast, higher baseline ACC activity is associated with improved outcomes [22].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [22]
In the citing paper
“In TRD specifically, rostral ACC function may mediate the balance between negative rumination and constructive self-evaluation, both facilitated by the DMN [17,22], suggesting that ACC dysfunction plays a role in excessive negative rumination.”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [22]
In the citing paper
“In both MDD and TRD, region-specific normalization of GABA concentrations in the occipital cortex (OCC), ACC, and DMN have repeatedly been observed in response to all successful antidepressant therapies [19,22,23,63].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence
Singer, J. D., & Willett, J. B. (2003) · doi:10.1093/acprof:oso/9780195152968.001.0001 · Cited by 10,647
The Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761
Development of a Rating Scale for Primary Depressive Illness
Hamilton, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Development and validation of a brief screening version of the Childhood Trauma Questionnaire
Bernstein, D. P., Stein, J. A., Newcomb, M. D., Walker, E., Pogge, D., Ahluvalia, T., Stokes, J., Handelsman, L., Medrano, M., Desmond, D., et al. (2003) · Child Abuse & Neglect · doi:10.1016/s0145-2134(02)00541-0 · Cited by 6,419
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Self-citationSmall sample inference for fixed effects from restricted maximum likelihood
Kenward, M. G., & Roger, J. H. (1997) · Biometrics · doi:10.2307/2533558 · Cited by 4,552
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Self-citationRush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Self-citation
Flagged first, then by citations
1 of the 117 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- First, 2002, Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Non-Patient Edition (SCID-I/NP, 11/2002 revision)
Cited by
Sorted by citations
Mental health before and during the COVID-19 pandemic in two longitudinal UK population cohorts
Kwong, A. S. F., Pearson, R. M., Adams, M. J., Northstone, K., Tilling, K. M., Major‐Smith, D., Fawns‐Ritchie, C., Bould, H., Warne, N., Zammit, S., et al. (2020) · The British Journal of Psychiatry · doi:10.1192/bjp.2020.242 · Cited by 543
Prognosis and improved outcomes in major depression: a review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0460-3 · Cited by 482
Candidate biomarkers in psychiatric disorders: state of the field
Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 421
An electroencephalographic signature predicts antidepressant response in major depression
Wu, W., Zhang, Y., Jiang, J., Lucas, M. V., Fonzo, G. A., Rolle, C. E., Cooper, C., Chin-Fatt, C., Krepel, N., Cornelssen, C. A., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0397-3 · Cited by 302
Self-citationDissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics
Buch, A. M., & Liston, C. M. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00789-3 · Cited by 289
Widge, A. S., Bilge, M. T., Montana, R. E., Chang, W. C., Rodríguez, C. I., Deckersbach, T., Carpenter, L. L., Kalin, N. H., & Nemeroff, C. B. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17121358 · Cited by 200
Machine learning and big data in psychiatry: toward clinical applications
Rutledge, R. B., Chekroud, A. M., & Huys, Q. J. M. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.02.006 · Cited by 206
Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study
Webb, C. A., Trivedi, M. H., Cohen, Z. D., Dillon, D. G., Fournier, J. C. J., Goer, F., D, M. F. M., McGrath, P. J., Weissman, M. M., Parsey, R. V., et al. (2018) · Psychological Medicine · doi:10.1017/s0033291718001708 · Cited by 177
Self-citationToward Circuit Mechanisms of Pathophysiology in Depression
Spellman, T., & Liston, C. M. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20030280 · Cited by 180
Widge, A. S., Zorowitz, S., Basu, I., Paulk, A. C., Cash, S. S., Eskandar, E. N., Deckersbach, T., Miller, E. K., & Dougherty, D. D. (2019) · Nature Communications · doi:10.1038/s41467-019-09557-4 · Cited by 152
Jaworska, N., de la Salle, S., Ibrahim, M. H., Blier, P., & Knott, V. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00768 · Cited by 106
Webb, C. A., Cohen, Z. D., Beard, C., Forgeard, M. J. C., Peckham, A., & Björgvinsson, Þ. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000451 · Cited by 96
Self-citationRolle, C. E., Fonzo, G. A., Wu, W., Toll, R. T., Jha, M. K., Cooper, C. M., Fatt, C. C., Pizzagalli, D. A., Trombello, J. M., Deckersbach, T., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3867 · Cited by 90
Self-citationBailey, N. W., Hoy, K. E., Rogasch, N. C., Thomson, R. H., McQueen, S., Elliot, D., Sullivan, C., Fulcher, B., Daskalakis, Z. J., & Fitzgerald, P. B. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.058 · Cited by 96
Intrinsic Brain Network Biomarkers of Antidepressant Response: a Review
Dunlop, K., Talishinsky, A., & Liston, C. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1072-6 · Cited by 80
Whitton, A. E., Webb, C. A., Dillon, D. G., Jürgen Kayser, A., Rutherford, A. V., Goer, F., D, M. F. M., McGrath, P. J., Weissman, M. M., Parsey, R. V., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.12.007 · Cited by 69
Self-citationKlooster, D., Voetterl, H., Baeken, C., & Arns, M. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.09.009 · Cited by 64
Köhler‐Forsberg, K., Jorgensen, A., Dam, V. H., Stenbæk, D. S., Fisher, P. M., Ip, C.-T., Ganz, M., Poulsen, H. E., Giraldi, A. G. E., Ozenne, B., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00641 · Cited by 67
Prognosis and Improved Outcomes in Major Depression: A Review
Kraus, C., Kadriu, B., Lanzenberger, R. R., Zarate, C. A., & Kasper, S. F. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.18205 · Cited by 64
Brain regulation of emotional conflict predicts antidepressant treatment response for depression
Fonzo, G. A., Etkin, A., Zhang, Y., Wu, W., Cooper, C. M., Fatt, C. C., Jha, M. K., Trombello, J. M., Deckersbach, T., Adams, P., et al. (2019) · Nature Human Behaviour · doi:10.1038/s41562-019-0732-1 · Cited by 57
Self-citationZhou, Z., Gao, Y., Bao, W., Liang, K., Cao, L., Tang, M., Li, H., Hu, X., Zhang, L., Sun, H., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105583 · Cited by 53
Meyer, B. M., Rabl, U., Huemer, J., Bartova, L., Kalcher, K., Provenzano, J., Brandner, C., Sezen, P., Kasper, S., Schatzberg, A. F., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0395-8 · Cited by 52
Jiang, C.-Y., Qin, X., Yuan, M.-M., Lu, G.-J., & Cheng, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9501427 · Cited by 53
Brown, E. C., Clark, D., Forkert, N. D., Molnar, C., Kiss, Z. H. T., & Ramasubbu, R. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0745-5 · Cited by 53
Trivedi, M. H., South, C. C., Jha, M. K., Rush, A. J., Cao, J., Kurian, B. T., Phillips, M. L., Pizzagalli, D. A., Trombello, J. M., Oquendo, M. A., et al. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491093 · Cited by 49
Self-citationPharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
Vecera, C. M., C. Courtes, A., Jones, G., Soares, J. C., & Machado-Vieira, R. (2023) · Pharmaceuticals · doi:10.3390/ph16111572 · Cited by 48
“In both MDD and TRD, region-specific normalization of GABA concentrations in the occipital cortex (OCC), ACC, and DMN have repeatedly been observed in response to all successful antidepressant therapies [19,22,23,63].”
BackgroundElias, G. J. B., Germann, J., Boutet, A., Pancholi, A., Beyn, M. E., Bhatia, K. D., Neudorfer, C., Loh, A., Rizvi, S. J., Bhat, V., et al. (2021) · Brain · doi:10.1093/brain/awab284 · Cited by 49
3T MRI of rapid brain activity changes driven by subcallosal cingulate deep brain stimulation
Elias, G. J. B., Germann, J., Boutet, A., Loh, A., Li, B. C. W., Pancholi, A., Beyn, M. E., Naheed, A., Bennett, N., Pinto, J., et al. (2021) · Brain · doi:10.1093/brain/awab447 · Cited by 49
McVoy, M. K., Aebi, M. E., Loparo, K. A., Lytle, S., Morris, A., Woods, N., Deyling, E. A., Tatsuoka, C. M., Kaffashi, F., Lhatoo, S. D., et al. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0166 · Cited by 47
Greenberg, T., Fournier, J. C. J., Stiffler, R. S., Chase, H. W., Almeida, J., Aslam, H. A., Deckersbach, T., Cooper, C. M., Toups, M. S. P., Carmody, T., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0490-5 · Cited by 48
Self-citationVoetterl, H., Sack, A. T., Olbrich, S., Stuiver, S., Rouwhorst, R., Prentice, A., Pizzagalli, D. A., van der Vinne, N., van Waarde, J. A., Brunovský, M., et al. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00160-7 · Cited by 46
Self-citationJiao, Y., Zhao, K., Wei, X., Carlisle, N. B., Keller, C. J., Oathes, D. J., Fonzo, G. A., & Zhang, Y. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02974-6 · Cited by 51
Dang, W., Gao, Z., Sun, X., Li, R., Cai, Q., & Grebogi, C. (2020) · Nonlinear Dynamics · doi:10.1007/s11071-020-05665-9 · Cited by 43
Ang, Y., Kaiser, R. H., Deckersbach, T., Almeida, J., Phillips, M. L., Chase, H. W., Webb, C. A., Parsey, R. V., D, M. F. M., McGrath, P. J., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.04.009 · Cited by 43
Self-citationJamieson, A. J., Harrison, B. J., Razi, A., & Davey, C. G. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01214-z · Cited by 41
Quantitative Electroencephalography in Guiding Treatment of Major Depression
Schiller, M. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00779 · Cited by 40
EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial
van der Vinne, N., Vollebregt, M. A., Rush, A. J., Eebes, M., van Putten, M. J. A. M., & Arns, M. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.12.005 · Cited by 39
Smith, E. E., Tenke, C. E., Deldin, P. J., Trivedi, M. H., Weissman, M. M., Auerbach, R. P., Bruder, G. E., Pizzagalli, D. A., & Jürgen Kayser, A. (2019) · Psychophysiology · doi:10.1111/psyp.13483 · Cited by 38
Self-citationMertse, N., Denier, N., Walther, S., Breit, S., Grosskurth, E. D., Federspiel, A., Wiest, R., & Bracht, T. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.01.035 · Cited by 38
Ip, C.-T., Olbrich, S., Ganz, M., Ozenne, B., Köhler‐Forsberg, K., Dam, V. H., Beniczky, S., Jørgensen, M. B., Frøkjær, V. G., Søgaard, B., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.03.024 · Cited by 34
Yuan, H., Zhu, X. L., Tang, W., Cai, Y., Shi, S., & Luo, Q. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.09.041 · Cited by 31
A resting state fMRI study of major depressive disorder with and without anxiety
Li, G., Liu, P.-H., Zhang, A., Andari, E., & Zhang, K. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114697 · Cited by 33
Walsh, E., Eisenlohr-Moul, T., Minkel, J., Bizzell, J., Petty, C., Crowther, A. J., Carl, H., Smoski, M., & Dichter, G. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.065 · Cited by 33
An electroencephalographic signature predicts craving for methamphetamine
Tian, W., Zhao, D., Ding, J., Zhan, S., Zhang, Y., Etkin, A., Wu, W., & Yuan, T. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101347 · Cited by 31
NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD
Ip, C.-T., Ganz, M., Dam, V. H., Ozenne, B., Rüesch, A., Köhler‐Forsberg, K., Jørgensen, M. B., Frøkjær, V. G., Søgaard, B., Christensen, S. R., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.06.021 · Cited by 30
Tsai, Y., Li, C., & Juan, C.-H. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1073984 · Cited by 32
Cooper, C. M., Fatt, C. C., Jha, M. K., Fonzo, G. A., Grannemann, B. D., Carmody, T. J., Ali, A., Aslan, S., Almeida, J., Deckersbach, T., et al. (2019) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.04.007 · Cited by 29
Self-citationYu, M., Cullen, N. C., Linn, K. A., Oathes, D. J., Seok, D., Cook, P. A., Duprat, R., Aselcioglu, I., Moore, T. M., Davatzikos, C. A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01039-8 · Cited by 29
Self-citationSun, P., Zhang, S., Jiang, L., Ma, Z., Yao, C., Zhu, Q., & Fang, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.956316 · Cited by 29
Kesebir, S., & Yosmaoğlu, A. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00741 · Cited by 29
Huang, S., Yu, Y., Chen, H.-H., Hung, C.-C., Wang, Y.-T., Chang, C. H., Peng, S., & Kuo, P. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04958-8 · Cited by 28
Homan, S., Muscat, W., Joanlanne, A., Marousis, N., Cecere, G., Hofmann, L. A., Ji, E., Neumeier, M. S., Vetter, S., Seifritz, E., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.11.033 · Cited by 29
Li, X., Zhang, Y., Meng, C., Zhang, C., Zhao, W., Zhu, D., & Zhu, J. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110396 · Cited by 27
Nguyen, K. P., Fatt, C. C., Treacher, A., Mellema, C., Cooper, C. M., Jha, M. K., Kurian, B. T., D, M. F. M., McGrath, P. J., Weissman, M. M., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.09.011 · Cited by 28
Self-citationData-Driven Approaches to Neuroimaging Analysis to Enhance Psychiatric Diagnosis and Therapy
Zhang, X., Braun, U., Tost, H., & Bassett, D. S. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.12.015 · Cited by 31
Wu, G., Wang, X., & Baeken, C. (2019) · Human Brain Mapping · doi:10.1002/hbm.24828 · Cited by 25
A Unique Brain Connectome Fingerprint Predates and Predicts Response to Antidepressants
Nemati, S., Akiki, T. J., Roscoe, J., Ju, Y., Averill, C. L., Fouda, S., Dutta, A., McKie, S., Krystal, J. H., Deakin, J. F. W., et al. (2019) · iScience · doi:10.1016/j.isci.2019.100800 · Cited by 28
Zilcha-Mano, S., & Webb, C. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.609585 · Cited by 25
Self-citationNishida, K., Koshikawa, Y., Morishima, Y., Yoshimura, M., Katsura, K., Ueda, S., Ikeda, S., Ishii, R., Pascual-Marqui, R. D., & Kinoshita, T. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00266 · Cited by 25
Banica, I., Sandre, A., Shields, G. S., Slavich, G. M., & Weinberg, A. (2021) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-021-00883-z · Cited by 31
Tsai, Y., Li, C., Liang, W., Muggleton, N. G., Tsai, C., Huang, N. E., & Juan, C.-H. (2021) · Human Brain Mapping · doi:10.1002/hbm.25740 · Cited by 23
Zhang, Y., Lei, L., Liu, Z., Gao, M., Liu, Z., Sun, N., Yang, C., Zhang, A., Wang, Y., & Zhang, K. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.827536 · Cited by 26
Resting and TMS-EEG markers of treatment response in major depressive disorder: A systematic review
Strafella, R., Chen, R. E., Rajji, T. K., Blumberger, D. M., & Voineskos, D. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.940759 · Cited by 23
Weigand, A., Gärtner, M., Scheidegger, M., Wyss, P. O., Henning, A., Seifritz, E., Stippl, A., Herrera-Meléndez, A. L., Bajbouj, M., Aust, S., et al. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac049 · Cited by 22
Pilot Study of An Intracranial Electroencephalography Biomarker of Depressive Symptoms in Epilepsy
Scangos, K. W., Ahmad, H. S., Shafi, A., Sellers, K. K., Dawes, H. E., Krystal, A. D., & Chang, E. F. (2019) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19030081 · Cited by 23
Nikolin, S., Martin, D. M., Loo, C. K. A., Iacoviello, B. M., & Boonstra, T. W. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14656 · Cited by 22
Kim, M., Lee, T. H., Park, H., Moon, S., Lho, S. K., & Kwon, J. S. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01180-6 · Cited by 25
EEG Biomarkers to Predict Response to Sertraline and Placebo Treatment in Major Depressive Disorder
Oakley, T., Coskuner, J., Cadwallader, A., Ravan, M., & Hasey, G. (2022) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2022.3204861 · Cited by 22
Predictive Biomarkers of Treatment Response in Major Depressive Disorder
Stolz, L. A., Kohn, J. N., Smith, S. E., Benster, L. L., & Appelbaum, L. G. (2023) · Brain Sciences · doi:10.3390/brainsci13111570 · Cited by 22
Tong, X., Xie, H., Wu, W., Keller, C. J., Fonzo, G. A., Chidharom, M., Carlisle, N. B., Etkin, A., & Zhang, Y. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.177 · Cited by 22
Koshiyama, D., Kirihara, K., Usui, K., Tada, M., Fujioka, M., Morita, S., Kawakami, S., Yamagishi, M., Sakurada, H., Sakakibara, E., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.030 · Cited by 22
Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder
Fan, S., Nemati, S., Akiki, T. J., Roscoe, J., Averill, C. L., Fouda, S., Averill, L. A., & Abdallah, C. G. (2020) · Chronic Stress · doi:10.1177/2470547020984726 · Cited by 20
Suppressed activity of the rostral anterior cingulate cortex as a biomarker for depression remission
Davey, C. G., Cearns, M., Jamieson, A. J., & Harrison, B. J. (2021) · Psychological Medicine · doi:10.1017/s0033291721004323 · Cited by 21
Chao, Z. C., Dillon, D. G., Liu, Y.-H., Barrick, E. M., & Wu, C. (2022) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.220046 · Cited by 20
Self-citationJones, C., & Nemeroff, C. B. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_27 · Cited by 23
Campanella, S., Arikan, K., Babiloni, C., Balconi, M., Bertollo, M., Betti, V., Bianchi, L., Brunovský, M., Buttinelli, C., Comani, S., et al. (2020) · Clinical EEG and Neuroscience · doi:10.1177/1550059420954054 · Cited by 21
Luo, X., Zhu, D., Li, J., Ren, M., Liu, Y., Si, T., & Chen, Y. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115391 · Cited by 19
Boucherie, D. E., Reneman, L., Ruhé, H. G., & Schrantee, A. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103517 · Cited by 23
Prompiengchai, S., & Dunlop, K. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01907-1 · Cited by 23
Bareš, M., Novák, T., Vlček, P., Hejzlar, M., & Brunovský, M. (2019) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2019.06.006 · Cited by 19
(2020) · Advances in Pharmacology · doi:10.1016/bs.apha.2020.04.003 · Cited by 18
Utility of Cognitive Neural Features for Predicting Mental Health Behaviors
Kato, R., Balasubramani, P. P., Ramanathan, D., & Mishra, J. (2022) · Sensors · doi:10.3390/s22093116 · Cited by 21
Li, C., Chen, C.-S., Cheng, C., Chen, C.-P., Chen, J.-P., Chen, M., Bai, Y., & Tsai, S. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.08.059 · Cited by 16
Barreiros, A. R., Breukelaar, I. A., Prentice, A., Mayur, P. M., Tomimatsu, Y., Funayama, K., Foster, S., Malhi, G. S., Arns, M., Harris, A. D., et al. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103656 · Cited by 14
Thai, M., Olson, E. A., Nickels, S., Dillon, D. G., Webb, C. A., Ren, B., Killgore, W. D. S., Rauch, S. L., Rosso, I. M., & Pizzagalli, D. A. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03020-9 · Cited by 13
Self-citationGärtner, M., Weigand, A., Scheidegger, M., Lehmann, M., Wyss, P. O., Wunder, A., Henning, A., & Grimm, S. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01377-2 · Cited by 13
Li, C., Cheng, C., Juan, C.-H., Tsai, Y., Chen, M., Bai, Y., Tsai, S., & Su, T. (2021) · Chronic Stress · doi:10.1177/24705470211006855 · Cited by 14
Ang, Y.-S., Bruder, G. E., Keilp, J. G., Rutherford, A., Alschuler, D. M., Pechtel, P., Webb, C. A., Carmody, T., Fava, M., Cusin, C., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291720004286 · Cited by 12
Self-citationCingulate-mediated depressive symptoms in neurologic disease and therapeutics
Riva‐Posse, P., Holtzheimer, P. E., & Mayberg, H. S. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64196-0.00021-2 · Cited by 14
Cook, I. A., Hunter, A. M., Caudill, M. M., Abrams, M., & Leuchter, A. F. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.02.028 · Cited by 12
Guan, Z., Zhang, X., Huang, W., Li, K., Chen, D., Li, W., Sun, J., Chen, L., Mao, Y., Sun, H., et al. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-024-01319-7 · Cited by 12
Olbrich, S., Jahn, I., & Stengler, K. (2019) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465819000213 · Cited by 11
Nishida, K., Morishima, Y., Pascual-Marqui, R. D., Minami, S., Yamane, T., Michikura, M., Ishikawa, H., & Kinoshita, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-02177-3 · Cited by 11
Godlewska, B. R. (2020) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-020-00198-2 · Cited by 15
BMRMI Reduces Depressive Rumination Possibly through Improving Abnormal FC of Dorsal ACC
Yang, M., Guo, Z., Lv, X., Zhang, Z.-Q., Wang, W., Wang, J., Hong, L., Lin, Y.-N., & Liu, C.-H. (2022) · Neural Plasticity · doi:10.1155/2022/8068988 · Cited by 12
Predicting antidepressant response by electroencephalography
Michel, C. M., & Pascual‐Leone, Á. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0476-5 · Cited by 10
Time-frequency signatures evoked by single-pulse deep brain stimulation to the subcallosal cingulate
Smith, E. E., Choi, K. S., Veerakumar, A., Obatusin, M., Howell, B. L., Smith, A. H., Tiruvadi, V., Crowell, A. L., Riva‐Posse, P., Alagapan, S., et al. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.939258 · Cited by 10
Reduced frontocingulate theta connectivity during emotion regulation in major depressive disorder
Steinmann, S., Tiedemann, K. J., Kellner, S., Wellen, C. M., Haaf, M., Mulert, C., Rauh, J., & Leicht, G. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.03.022 · Cited by 9
Zhou, H., Xiong, T., Dai, Z., Zou, H., Wang, X., Tang, H., Huang, Y., Sun, H., You, W., Yao, Z., et al. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01628-4 · Cited by 10
Mol, G. J. J., Runia, N., van Wingen, G. A., Denys, D. A. J. P., Mocking, R. J. T., & Bergfeld, I. O. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119387 · Cited by 10
Metadata
- Authors
- Pizzagalli, D. A., Webb, C. A., Dillon, D. G., Tenke, C. E., Kayser, J., Goer, F., Fava, M., McGrath, P., Weissman, M., Parsey, R., Adams, P., Trombello, J., Cooper, C., Deldin, P., Oquendo, M. A., McInnis, M. G., Carmody, T., Bruder, G., & Trivedi, M. H.
- Affiliations
- Harvard University (US)
- New York State Psychiatric Institute (US)
- Department of Psychiatry, New York State Psychiatric Institute & Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York
- Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston
- Stony Brook University (US)
- The University of Texas Southwestern Medical Center (US)
- University of Michigan (US)
- Department of Psychiatry, University of Pennsylvania, Perelman School of Medicine, Philadelphia
- Corresponding author
- Pizzagalli, Diego A.
- ORCID
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2018-06-01
- Volume
- 75
- Issue
- 6
- Pages
- 547
- ISSN
- 2168-622X (ISSN-L)
- PMC
- PMC6083825
- OpenAlex
- W2797156514
- Cited by
- 189
- References
- 117
- Citations by year
- 2026: 19 · 2025: 16 · 2024: 18 · 2023: 19 · 2022: 16 · 2021: 41 · 2020: 25 · 2019: 27 · 2018: 8
- FWCI
- 16.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Psychiatry (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- John Templeton Foundation
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Novartis
- Sanofi
- Teva Pharmaceutical Industries
- Sunovion
- National Alliance for Research on Schizophrenia and Depression
- Vanda Pharmaceuticals
- Arcadia Fund
- Avanir Pharmaceuticals
- Cerecor
- Supernus Pharmaceuticals
- American Society of Clinical Psychopharmacology
- Usona Institute
- Otsuka America
- Belvoir Media Group
- Vistagen Therapeutics
- University of Oxford
- Servier
- H. Lundbeck A/S
- Agency for Healthcare Research and Quality
- Allergan
- National Institute of Mental Health (R00MH094438, U01MH092250, K23MH108752, U01MH092221)
- National Institute of Diabetes and Digestive and Kidney Diseases
- Janssen Research and Development
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- major depressive disorder, rostral anterior cingulate cortex, theta activity, resting-state EEG, antidepressant response prediction, sertraline, source localization, Hamilton Depression Rating Scale, incremental predictive validity
- MeSH terms
- Adult, Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Electroencephalography, Female, Gyrus Cinguli, Humans, Male, Middle Aged, Prognosis, Theta Rhythm, Treatment Outcome, Sertraline, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review